BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1435772)

  • 21. Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus.
    Haishi S; Imai H; Hirai K; Igarashi A; Kato S
    Acta Virol; 1989 Dec; 33(6):497-503. PubMed ID: 2576591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SP6 RNA polymerase containing vaccinia virus for rapid expression of cloned genes in tissue culture.
    Usdin TB; Brownstein MJ; Moss B; Isaacs SN
    Biotechniques; 1993 Feb; 14(2):222-4. PubMed ID: 8431286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and structural-functional studies for 7.5k promoter of Tiantan strain of vaccinia virus.
    Wang SP; Ruan L; Jin Q; Cao X; Zhu JM
    Sci China B; 1993 Jan; 36(1):60-7. PubMed ID: 8503987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses.
    Carroll MW; Moss B
    Biotechniques; 1995 Sep; 19(3):352-4, 356. PubMed ID: 7495543
    [No Abstract]   [Full Text] [Related]  

  • 25. [Synthesis of the E-antigen of the hepatitis B virus (HBeAg) in eukaryotic cells by a recombinant strain of the vaccinia virus].
    Loparev VN; Araslanov RR; Mitina IV; Chernos VI
    Mol Gen Mikrobiol Virusol; 1991 Sep; (9):3-6. PubMed ID: 1745274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinants between vaccinia and ectromelia viruses bearing the specific pathogenicity markers of both parents.
    Chernos VI; Antonova TP; Senkevich TG
    J Gen Virol; 1985 Mar; 66 ( Pt 3)():621-6. PubMed ID: 2983005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Search for unique segments of the ectromelia virus genome by cross blot hybridization with DNA from other orthopoxviruses].
    Senkevich TG; Muravnik GL; Chernos VI
    Mol Gen Mikrobiol Virusol; 1992; (9-10):13-5. PubMed ID: 1298880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of a synthetic gene for human angiogenin in a recombinant vaccinia virus].
    Netesova NA; Petrova VS; Cheshenko NV; Chikaev NA; Malygin EG; Mertvetsov NP
    Bioorg Khim; 1995 Aug; 21(8):608-11. PubMed ID: 8540901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering recombinant poxviruses using a compact GFP-blasticidin resistance fusion gene for selection.
    Wong YC; Lin LC; Melo-Silva CR; Smith SA; Tscharke DC
    J Virol Methods; 2011 Jan; 171(1):295-8. PubMed ID: 21073901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient expression system to measure the efficiency of vaccinia promoter regions.
    Shepard B; Panicali D; Huang C
    Plasmid; 1987 Jul; 18(1):16-23. PubMed ID: 3321110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Orthopoxvirus genes for kelch-like proteins. III. Construction of mousepox (ectromelia) virus variants with targeted gene deletions].
    Kochneva GV; Kolosova IV; Lupan TA; Sivolobova GF; Iudin PV; Grazhdantseva AA; Riabchikova EI; Kandrina NIu; Shchelkunov SN
    Mol Biol (Mosk); 2009; 43(4):616-22. PubMed ID: 19807023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleotide sequence of XhoI O fragment of ectromelia virus DNA reveals significant differences from vaccinia virus.
    Senkevich TG; Muravnik GL; Pozdnyakov SG; Chizhikov VE; Ryazankina OI; Shchelkunov SN; Koonin EV; Chernos VI
    Virus Res; 1993 Oct; 30(1):73-88. PubMed ID: 8266721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of an immunoperoxidase method in situ for detecting recombinant clones of vaccinia virus containing an expressed gene of influenza viral hemagglutinins].
    Selivanova TK; Leonov SV; Filatov FP; Iuferov VP; Garaev MM; Bobkov AF; Rassulin IuIu; Khizhniakova TM; Uryvaev LV; Kharitonenkov IG
    Vopr Virusol; 1989; 34(5):576-9. PubMed ID: 2692303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae.
    Hughes SJ; Johnston LH; de Carlos A; Smith GL
    J Biol Chem; 1991 Oct; 266(30):20103-9. PubMed ID: 1657913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells.
    Kerr SM; Smith GL
    Virology; 1991 Feb; 180(2):625-32. PubMed ID: 1989387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conservation and variation in Orthopoxvirus genome structure.
    Mackett M; Archard LC
    J Gen Virol; 1979 Dec; 45(3):683-701. PubMed ID: 232137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro recognition of an orf virus early promoter in a vaccinia virus extract.
    Vos JC; Mercer AA; Fleming SB; Robinson AJ
    Arch Virol; 1992; 123(1-2):223-8. PubMed ID: 1312824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of vaccinia virus late promoters.
    Davison AJ; Moss B
    J Mol Biol; 1989 Dec; 210(4):771-84. PubMed ID: 2515287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dominant selectable marker for the construction of recombinant poxviruses.
    Boyle DB; Coupar BE
    Gene; 1988 May; 65(1):123-8. PubMed ID: 2840353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins.
    Davison AJ; Moss B
    Nucleic Acids Res; 1990 Jul; 18(14):4285-6. PubMed ID: 2377486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.